Literature DB >> 29291999

Serological and virological survey of hepatitis E virus (HEV) in animal reservoirs from Uruguay reveals elevated prevalences and a very close phylogenetic relationship between swine and human strains.

Santiago Mirazo1, Noemí R Gardinali2, D'Albora Cecilia3, Lorenzo Verger4, Florencia Ottonelli3, Natalia Ramos3, Gustavo Castro5, Marcelo A Pinto2, Viviana Ré6, Belén Pisano6, Alejandra Lozano4, Jaqueline Mendes de Oliveira2, Juan Arbiza3.   

Abstract

Hepatitis E virus (HEV) infection is an issue of public health concern in high-income and non-endemic countries. Increasing evidence supports the hypothesis of a zoonotic route as the main mode of infection in this epidemiological setting, since the transmission of genotypes HEV-3 and HEV-4 from reservoirs to humans has been demonstrated. In America, studies have confirmed the circulation of HEV in pig herds but the zoonotic role of wild boars has never been evaluated. Uruguay has a high burden of HEV- associated acute hepatitis, and a close phylogenetic relationship was observed among human HEV-3 strains and European isolates detected in swine. However in this context, swine herds have never been surveyed. Herein is reported a survey of HEV in swine herds, pigs at slaughter-house and free-living wild boar populations. Two-hundred and twenty sera and 150 liver tissue samples from domestic pigs, and 140 sera from wild boars were tested for HEV by ELISA and PCR-based approaches. All tested swine farms resulted seropositive with an overall rate of 46.8%. In turn, 22.1% of the wild boars had anti-HEV antibodies. HEV RNA was detected in 16.6% and 9.3% of liver samples from slaughter-age pigs and adult wild boars sera, respectively. Three strains from domestic pig were also amplified by nested-PCR approaches. By contrast, none of the positive samples obtained from wild boars could be confirmed by nested-PCR. Phylogenetic analysis revealed a very high nucleotide identity among swine strains and sequences obtained from humans in Uruguay. Results showed that HEV is widely distributed among swine herds in Uruguay. Additionally, this study evidences for the first time in the American continent that wild boar populations are a reservoir for HEV, though its zoonotic role remains to be elucidated. Altogether, data presented here suggest a high zoonotic risk of HEV transmission from swine to humans.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Domestic pig; Hepatitis E virus; Survey; Wild boars

Mesh:

Substances:

Year:  2017        PMID: 29291999     DOI: 10.1016/j.vetmic.2017.11.013

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Hepatitis E virus genotype 3 in bovine livers slaughtered in the state of Rio Grande do Sul, Brazil.

Authors:  Caroline Bastos; Ana Karolina Antunes Eisen; Meriane Demoliner; Fágner Henrique Heldt; Micheli Filippi; Vyctoria Malayhka de Abreu Góes Pereira; Thais Alves Moreira Teixeira; Luan Oliveski Roth; Juliana Schons Gularte; Fernando Rosado Spilki
Journal:  Braz J Microbiol       Date:  2022-03-30       Impact factor: 2.214

Review 2.  Hepatitis E: Update on Prevention and Control.

Authors:  Juliana Gil Melgaço; Noemi Rovaris Gardinali; Vinicius da Motta de Mello; Mariana Leal; Lia Laura Lewis-Ximenez; Marcelo Alves Pinto
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

3.  Phylogenetic Analysis and Characterization of the Complete Hepatitis E Virus Genome (Zoonotic Genotype 3) in Swine Samples from Mexico.

Authors:  Alicia Sotomayor-González; María E Trujillo-Ortega; Blanca I Taboada-Ramírez; Carlos Sandoval-Jaime; Rosa E Sarmiento-Silva
Journal:  Viruses       Date:  2018-07-26       Impact factor: 5.048

4.  Comparative assessment of faecal microbial composition and metabonome of swine, farmers and human control.

Authors:  Shiang Chiet Tan; Chun Wie Chong; Ivan Kok Seng Yap; Kwai Lin Thong; Cindy Shuan Ju Teh
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.